UK regulator found 30 cases of blood clot events after AstraZeneca vaccine use

Reuters

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="https://sa.kapamilya.com/absnews/abscbnnews/media/2021/reuters/04/02/20210328-health-coronavirus-britain-vaccine.jpg"/><figcaption>A dose of the AstraZeneca COVID-19 vaccine is prepared in a vaccination center at Newmarket Racecourse, amid the coronavirus disease outbreak in Newmarket, Britain, March 26, 2021. <em>Andrew Couldridge, Reuters/File</em></figcaption></figure></div><p>British regulators said Thursday they had identified 30 cases of rare blood clot events after the use of the AstraZeneca COVID-19 vaccine, 25 more than the agency previously reported.</p><p>The Medicines and Healthcare products Regulatory Agency said it had received no such reports of clotting events following use of the vaccine made by BioNTech SE and Pfizer Inc .</p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/overseas/03/25/21/astrazeneca-covid-19-vaccine-76-pct-effective-in-new-analysis-of-us-trial">AstraZeneca COVID-19 vaccine 76 pct effective in new analysis of US trial</a></li></ul><p>The health officials said they still believed the benefits of the vaccine in the prevention of COVID-19 far outweigh any possible risk of blood clots.</p><p>Some countries are restricting use of the AstraZeneca vaccine while others have resumed inoculations, as investigations into reports of rare, and sometimes severe, blood clots continue.</p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/overseas/03/19/21/eu-countries-to-resume-astrazeneca-jabs-after-safe-verdict">EU countries to resume AstraZeneca jabs after &#x27;safe&#x27; verdict</a></li></ul><p>On March 18, the UK medicines regulator said that there had been 5 cases of a rare brain blood clot among 11 million administered shots.</p><p>On Thursday, it put the count at 22 reports of cerebral venous sinus thrombosis, an extremely rare brain clotting ailment, and 8 reports of other clotting events associated with low blood platelets out of a total of 18.1 million doses given.</p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/overseas/03/18/21/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who">Benefits outweigh the risks of AstraZeneca COVID shot as review continues: WHO</a></li></ul><div><strong>RELATED VIDEO</strong></div><figure class="op-interactive"><iframe height="315" src="https://www.youtube.com/embed/pokW8N-nwLw?enablejsapi=1" width="560"></iframe></figure><div class="iwantbar">Watch more in <a href="//www.iwantv.com.ph/">iWantv</a> or <a href="//tfc.tv/">TFC.tv</a></div>

<p>British regulators said Thursday they had identified 30 cases of rare blood clot events after the use of the AstraZeneca COVID-19 vaccine, 25 more than the agency previously reported.</p>

British regulators said Thursday they had identified 30 cases of rare blood clot events after the use of the AstraZeneca COVID-19 vaccine, 25 more than the agency previously reported.

UK regulator found 30 cases of blood clot events after AstraZeneca vaccine use | ABS-CBN

Entertainment

News

Metro.Style

Sports

More

Overseas

UK regulator found 30 cases of blood clot events after AstraZeneca vaccine use

UK regulator found 30 cases of blood clot events after AstraZeneca vaccine use

Reuters

Published Apr 02, 2021 09:20 AM PHT

|

Updated Apr 02, 2021 10:20 AM PHT

Read More:

ANC

UK regulator AstraZeneca blood clot

AstraZeneca COVID-19 vaccine blood clot

COVID-19 vaccine blood clot

AstraZeneca COVID-19 vaccine

AstraZeneca

blood clot

COVID-19

COVID-19 vaccine

Medicines and Healthcare products Regulatory Agency

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

Terms of Service

Advertise with Us

© 2024 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Advertise with Us

Privacy Policy

Terms of Service

© 2024 ABS-CBN Corporation. All Rights Reserved.